Hidden Markov model tracking of continuous gravitational waves from a neutron star with wandering spin

Gravitational wave searches for continuous-wave signals from neutron stars are especially challenging when the star's spin frequency is unknown a priori from electromagnetic observations and wanders stochastically under the action of internal (e.g. superfluid or magnetospheric) or external (e.g. accretion) torques. It is shown that frequency tracking by hidden Markov model (HMM) methods can be combined with existing maximum likelihood coherent matched filters like the F-statistic to surmount some of the challenges raised by spin wandering. Specifically it is found that, for an isolated, biaxial rotor whose spin frequency walks randomly, HMM tracking of the F-statistic output from coherent segments with duration T_drift = 10d over a total observation time of T_obs = 1yr can detect signals with wave strains h0 > 2e-26 at a noise level characteristic of the Advanced Laser Interferometer Gravitational Wave Observatory (Advanced LIGO). For a biaxial rotor with randomly walking spin in a binary orbit, whose orbital period and semi-major axis are known approximately from electromagnetic observations, HMM tracking of the Bessel-weighted F-statistic output can detect signals with h0 > 8e-26. An efficient, recursive, HMM solver based on the Viterbi algorithm is demonstrated, which requires ~10^3 CPU-hours for a typical, broadband (0.5-kHz) search for the low-mass X-ray binary Scorpius X-1, including generation of the relevant F-statistic input. In a "realistic" observational scenario, Viterbi tracking successfully detects 41 out of 50 synthetic signals without spin wandering in Stage I of the Scorpius X-1 Mock Data Challenge convened by the LIGO Scientific Collaboration down to a wave strain of h0 = 1.1e-25, recovering the frequency with a root-mean-square accuracy of <= 4.3e-3 Hz

A method for controlling the color rendering index for led RGBW modules

В статье предложен метод управления яркостями компонентов светодиодных модулей RGBW с использованием широтно-импульсной модуляции. Метод позволяет регулировать значение индекса цветопередачи Ra при фиксированных значениях цветности и общей яркости. Это даёт возможность управлять визуально воспринимаемой насыщенностью зелёных и красных цветов отражающих объектов. Экспериментальная проверка метода показала линейность изменения Ra в зависимости от яркости белого светодиода.This article proposes a method for controlling the components brightness of the RGBW led module using pulse-width modulation. The method allows adjusting the value of color rendering index Ra with fixed values of chromaticity and overall brightness. It`s allows to control visually perceived saturation of the green and red colors of reflective objects. Experimental verification of the method showed linearity Ra changes depending on the brightness of the white led

Neutralino Dark Matter beyond CMSSM Universality

We study the effect of departures from SUSY GUT universality on the neutralino relic density and both its direct detection and indirect detection, especially by neutrino telescopes. We find that the most interesting models are those with a value of $M_3|_{GUT}$ lower than the universal case.Comment: 20 pages, 12 figures, JHEP format. Figures improved for B&W, references added, typos and english correcte

Higgs Bosons and the Indirect Search for WIMPs

We investigated the contribution of the MSSM Higgs bosons produced in the neutralino annihilation in the Earth and Sun to the total WIMPs detection signals. We found that this contribution is very important and results in a lower bound for the muon flux from the Sun of 10^{-7} - 10^{-8} m^{-2} yr^{-1} for neutralinos heavier than 200 GeV. We noticed that due to the SUSY charged Higgs bosons one can expect an energetic tau neutrino flux from the Sun at a level of 10^2 m^{-2} yr^{-1}.Comment: 10 pages, 4 figures. Talk given at Dark2000, Heidelberg, Germany, 10-15 July, 200

Upgraded LED illuminator for colorimetric research

В статье описана экспериментальная осветительная установка с использованием стандартных светоизлучающих диодов. Управление яркостью светодиодных компонентов осуществляется при помощи автоматизированной системы, представляющей собой комплекс драйверов с широтно-импульсной модуляцией. Исследуемая экспериментальная осветительная установка предназначена для регулирования значения индекса цветопередачи при фиксированных цветности и общей яркости, что позволяет управлять визуально-воспринимаемой насыщенностью зелёных и красных цветов отражающих объектов.The article describes an experimental lighting system using standard light-emitting diodes. Brightness of light-emitting iodes components are managed using an automated system, which is a set of drivers with pulse width modulation. The researched experimental lighting system designed to regulate the value of the color rendering index at fixed chromaticity and brightness that makes possible to control visually perceived saturation of green and red colors reflecting objects

Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.

BACKGROUND: Dissociative seizures are paroxysmal events resembling epilepsy or syncope with characteristic features that allow them to be distinguished from other medical conditions. We aimed to compare the effectiveness of cognitive behavioural therapy (CBT) plus standardised medical care with standardised medical care alone for the reduction of dissociative seizure frequency. METHODS: In this pragmatic, parallel-arm, multicentre randomised controlled trial, we initially recruited participants at 27 neurology or epilepsy services in England, Scotland, and Wales. Adults (≥18 years) who had dissociative seizures in the previous 8 weeks and no epileptic seizures in the previous 12 months were subsequently randomly assigned (1:1) from 17 liaison or neuropsychiatry services following psychiatric assessment, to receive standardised medical care or CBT plus standardised medical care, using a web-based system. Randomisation was stratified by neuropsychiatry or liaison psychiatry recruitment site. The trial manager, chief investigator, all treating clinicians, and patients were aware of treatment allocation, but outcome data collectors and trial statisticians were unaware of treatment allocation. Patients were followed up 6 months and 12 months after randomisation. The primary outcome was monthly dissociative seizure frequency (ie, frequency in the previous 4 weeks) assessed at 12 months. Secondary outcomes assessed at 12 months were: seizure severity (intensity) and bothersomeness; longest period of seizure freedom in the previous 6 months; complete seizure freedom in the previous 3 months; a greater than 50% reduction in seizure frequency relative to baseline; changes in dissociative seizures (rated by others); health-related quality of life; psychosocial functioning; psychiatric symptoms, psychological distress, and somatic symptom burden; and clinical impression of improvement and satisfaction. p values and statistical significance for outcomes were reported without correction for multiple comparisons as per our protocol. Primary and secondary outcomes were assessed in the intention-to-treat population with multiple imputation for missing observations. This trial is registered with the International Standard Randomised Controlled Trial registry, ISRCTN05681227, and ClinicalTrials.gov, NCT02325544. FINDINGS: Between Jan 16, 2015, and May 31, 2017, we randomly assigned 368 patients to receive CBT plus standardised medical care (n=186) or standardised medical care alone (n=182); of whom 313 had primary outcome data at 12 months (156 [84%] of 186 patients in the CBT plus standardised medical care group and 157 [86%] of 182 patients in the standardised medical care group). At 12 months, no significant difference in monthly dissociative seizure frequency was identified between the groups (median 4 seizures [IQR 0-20] in the CBT plus standardised medical care group vs 7 seizures [1-35] in the standardised medical care group; estimated incidence rate ratio [IRR] 0·78 [95% CI 0·56-1·09]; p=0·144). Dissociative seizures were rated as less bothersome in the CBT plus standardised medical care group than the standardised medical care group (estimated mean difference -0·53 [95% CI -0·97 to -0·08]; p=0·020). The CBT plus standardised medical care group had a longer period of dissociative seizure freedom in the previous 6 months (estimated IRR 1·64 [95% CI 1·22 to 2·20]; p=0·001), reported better health-related quality of life on the EuroQoL-5 Dimensions-5 Level Health Today visual analogue scale (estimated mean difference 6·16 [95% CI 1·48 to 10·84]; p=0·010), less impairment in psychosocial functioning on the Work and Social Adjustment Scale (estimated mean difference -4·12 [95% CI -6·35 to -1·89]; p<0·001), less overall psychological distress than the standardised medical care group on the Clinical Outcomes in Routine Evaluation-10 scale (estimated mean difference -1·65 [95% CI -2·96 to -0·35]; p=0·013), and fewer somatic symptoms on the modified Patient Health Questionnaire-15 scale (estimated mean difference -1·67 [95% CI -2·90 to -0·44]; p=0·008). Clinical improvement at 12 months was greater in the CBT plus standardised medical care group than the standardised medical care alone group as reported by patients (estimated mean difference 0·66 [95% CI 0·26 to 1·04]; p=0·001) and by clinicians (estimated mean difference 0·47 [95% CI 0·21 to 0·73]; p<0·001), and the CBT plus standardised medical care group had greater satisfaction with treatment than did the standardised medical care group (estimated mean difference 0·90 [95% CI 0·48 to 1·31]; p<0·001). No significant differences in patient-reported seizure severity (estimated mean difference -0·11 [95% CI -0·50 to 0·29]; p=0·593) or seizure freedom in the last 3 months of the study (estimated odds ratio [OR] 1·77 [95% CI 0·93 to 3·37]; p=0·083) were identified between the groups. Furthermore, no significant differences were identified in the proportion of patients who had a more than 50% reduction in dissociative seizure frequency compared with baseline (OR 1·27 [95% CI 0·80 to 2·02]; p=0·313). Additionally, the 12-item Short Form survey-version 2 scores (estimated mean difference for the Physical Component Summary score 1·78 [95% CI -0·37 to 3·92]; p=0·105; estimated mean difference for the Mental Component Summary score 2·22 [95% CI -0·30 to 4·75]; p=0·084), the Generalised Anxiety Disorder-7 scale score (estimated mean difference -1·09 [95% CI -2·27 to 0·09]; p=0·069), and the Patient Health Questionnaire-9 scale depression score (estimated mean difference -1·10 [95% CI -2·41 to 0·21]; p=0·099) did not differ significantly between groups. Changes in dissociative seizures (rated by others) could not be assessed due to insufficient data. During the 12-month period, the number of adverse events was similar between the groups: 57 (31%) of 186 participants in the CBT plus standardised medical care group reported 97 adverse events and 53 (29%) of 182 participants in the standardised medical care group reported 79 adverse events. INTERPRETATION: CBT plus standardised medical care had no statistically significant advantage compared with standardised medical care alone for the reduction of monthly seizures. However, improvements were observed in a number of clinically relevant secondary outcomes following CBT plus standardised medical care when compared with standardised medical care alone. Thus, adults with dissociative seizures might benefit from the addition of dissociative seizure-specific CBT to specialist care from neurologists and psychiatrists. Future work is needed to identify patients who would benefit most from a dissociative seizure-specific CBT approach. FUNDING: National Institute for Health Research, Health Technology Assessment programme